Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease

BACKGROUND: Erythropoietin is a growth factor commonly used to manage anemia in patients with chronic kidney disease. A significant clinical challenge is relative resistance to erythropoietin, which leads to use of successively higher erythropoietin doses, failure to achieve target hemoglobin levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Khankin, Eliyahu V., Mutter, Walter P., Tamez, Hector, Yuan, Hai-Tao, Karumanchi, S. Ananth, Thadhani, Ravi
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821920/
https://www.ncbi.nlm.nih.gov/pubmed/20169072
http://dx.doi.org/10.1371/journal.pone.0009246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821920/
https://www.ncbi.nlm.nih.gov/pubmed/20169072
http://dx.doi.org/10.1371/journal.pone.0009246

Ejemplares similares